documents: FDA-2021-N-1351-0005
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2021-N-1351-0005 | FDA | FDA-2021-N-1351 | References 2 - Eastern Research Group, Inc. (2003), ‘‘The Pharmaceutical Labeling Revisions Cost Model’’ | Supporting & Related Material | Background Material | 2022-07-27T04:00:00Z | 2022 | 7 | 2022-07-27T19:08:19Z | 0 | 0 | 09000064851ea766 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref